🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Experimental Drug Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a robust trade exists on messaging services, where groups with numerous of members share comparison photos, administration instructions and claims of rapid British shipping. Vendors promote the drug there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

However, doctors and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of uncertain source.

Some professionals said the demand for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Response and Content Removal

Based on the social media company, the platform has removed problematic content and prohibited related keywords and search suggestions. The organization said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Trading Activities

Research also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, filled with images of slimming results, positive testimonials and step-by-step instructions for preparing or injecting at home.

Within minutes of entering one community, a seller shared WhatsApp details, where most purchases occur. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.

Item Information and Pricing

Within these communities, posts display black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When asked how long a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for the messaging service said it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they can’t verify. Although the research behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has previously encountered individuals harmed by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to potentially significant medical dangers”.